Logo

American Heart Association

  2
  0


Final ID:

Targeting Epigenetic Modifications is a Viable Disease Modifying Strategy for Patients with Pulmonary Hypertension: The Pros and Cons

  • Savai Pullamsetti, Soni  ( Max-Planck-Institute for Heart and Lung Research, Department of Lung Development and Remodeling , Bad Nauheim , Germany )
  • Michelakis, Evangelos  ( University of Alberta , Edmonton , Alberta , Canada )
  • Author Disclosures:
    Soni Savai Pullamsetti: DO NOT have relevant financial relationships | Evangelos Michelakis: No Answer
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

More abstracts on this topic:
Epigenetic Age in Pulmonary Hypertension: Is it Relevant?

Potus Francois, Rhodes Christopher

Epigenetic Mechanisms of Pulmonary Vascular Remodeling in Pulmonary Hypertension

Hadri Lahouaria, Stenmark Kurt, Goncharova Elena, Bonnet Sebastien

More abstracts from these authors:
NLRP3 signaling in rodent and human right ventricular failure is sexually dimorphic and regulated by 17β-estradiol via estrogen receptor α

Sobrano Fais Rafael, Givens Sophie, Bourgeois Alice, Woulfe Kc, Savai Pullamsetti Soni, Boucherat Olivier, Ogle Brenda, Bonnet Sebastien, Lahm Tim, Das Neves Palotta Fais Erica, Kopf Katrina, Mora Massad Karina, Hoffer Christopher, Walts Avram, Cook Todd, Fisher Amanda, Frump Andrea

A novel small molecule synthesized based on a snail hibernation model induces hibernation in mouse fibroblasts and perfused hearts

Piao Jiyuan, Zhang Yongneng, Zhao Yuan Yuan, Hannington Patrick, Tabatabaei Dakhili Seyed Amirhossein, Ussher John, Sutendra Gopinath, Michelakis Evangelos

You have to be authorized to contact abstract author. Please, Login
Not Available